13.5毫克、19.5毫克和52毫克左炔诺孕酮宫内节育系统与异位妊娠风险
该回顾性队列研究纳入瑞典斯德哥尔摩2014年1月1日至2019年12月31日诊断的2252例异位妊娠,其中94例使用已知类型左炔诺孕酮宫内节育系统并计算珍珠指数。结果显示13.5毫克、19.5毫克和52毫克系统的珍珠指数分别为0.136、0.037和0.009,剂量越低异位妊娠风险越高。作者建议对有异位妊娠危险因素的女性提供避孕咨询时可考虑更高剂量的左炔诺孕酮宫内节育系统。
要点
- 13.5毫克、19.5毫克和52毫克左炔诺孕酮宫内节育系统的异位妊娠珍珠指数分别为0.136、0.037和0.009。
- 以52毫克系统为参照,13.5毫克系统第一年异位妊娠的相对危险度为20.59。
- 整个研究期间,13.5毫克和19.5毫克系统相对52毫克系统的相对危险度分别为14.49和4.44。
核心结论
- 使用任何剂量的左炔诺孕酮宫内节育系统期间异位妊娠的绝对风险均低。
- 宫内节育系统剂量越低,异位妊娠风险越高。
- 作者建议对有异位妊娠已知危险因素且考虑激素宫内节育系统的女性提供避孕咨询时可考虑更高剂量的左炔诺孕酮宫内节育系统。
研究设计与样本
- 本研究为回顾性队列研究。
- 通过电子病历系统识别2014年1月1日至2019年12月31日瑞典斯德哥尔摩诊断的异位妊娠女性。
- 最终分析纳入2252例异位妊娠病例。
- 其中105例放置了已知类型的激素宫内节育系统,94例纳入珍珠指数计算。
主要发现
- 13.5毫克左炔诺孕酮宫内节育系统的异位妊娠珍珠指数为0.136(95% CI 0.106-0.176)。
- 19.5毫克左炔诺孕酮宫内节育系统的异位妊娠珍珠指数为0.037(95% CI 0.021-0.067)。
- 52毫克左炔诺孕酮宫内节育系统的异位妊娠珍珠指数为0.009(95% CI 0.006-0.014)。
- 以52毫克系统为参照,第一年异位妊娠的相对危险度:13.5毫克系统为20.59(95% CI 12.04-35.21)。
- 整个研究期间异位妊娠的相对危险度:13.5毫克系统为14.49(95% CI 9.01-23.3),19.5毫克系统为4.44(95% CI 1.64-12.00)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the Pearl Index for risk of ectopic pregnancy in women using levonorgestrel-releasing intrauterine systems (LNG-IUS) with hormonal reservoirs of 13.5 mg, 19.5 mg, or 52 mg. METHODS: This was a retrospective cohort study. Women diagnosed with an ectopic pregnancy in Stockholm County, Sweden, between January 1, 2014, and December 31, 2019, were identified through the electronic medical record system. The final analysis included 2,252 cases of ectopic pregnancy. Information on age, reproductive and medical history, as well as current use of contraception was retrieved. The time of intrauterine device (IUD) insertion before ectopic pregnancy and the numbers of sold LNG-IUS during the study period were used to calculate the incidence rate for ectopic pregnancy during use per 100 woman-years (Pearl Index). RESULTS: Among women with an ectopic pregnancy diagnosis, 105 presented with a known type of hormonal IUD in situ, of whom 94 were included in the calculations of the Pearl Index. The estimated Pearl Index for ectopic pregnancy was 0.136 (95% CI 0.106-0.176) for the LNG-IUS 13.5-mg, 0.037 (95% CI 0.021-0.067) for the LNG-IUS 19.5-mg, and 0.009 (95% CI 0.006-0.014) for the LNG-IUS 52-mg. With the 52-mg LNG-IUS as referent, the relative risk (RR) for ectopic pregnancy was higher during the first year for LNG 13.5-mg (RR 20.59, 95% CI 12.04-35.21), and for both 13.5-mg (RR 14.49, 95% CI 9.01-23.3) and 19.5-mg (RR 4.44, 95% CI 1.64-12.00) during the total study period. CONCLUSION: The absolute risk of ectopic pregnancy during the use of LNG-IUS at any doses was low. The results show that the lower the dose of the IUD, the higher the risk of an ectopic pregnancy. Higher-dose LNG-IUS should be considered when providing contraceptive counseling to a woman with known risk factors for ectopic pregnancy who are considering a hormonal IUD.
引用
- Elgemark K, Graner S, McTaggart J, et al. The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy. Obstet Gynecol. 2022. PMID: 35852273. doi:10.1097/AOG.0000000000004846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。